However, we definitely can conclude that the inhibition of necroptosis (regardless whether it is caused by hypomorphic ADAM17 or by loss of RIPK3) does neither ameliorate nor worsen the damage caused by DSS-induced colitis in ADAM17ex/ex mice, in line with the results obtained by Newton et al. in WT mice [42]. The gene discussed is RIPK3; the disease is colitis.